- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Net Ingredient Cost of antidiabetic drugs in England 2015/16, by type
Net Ingredient Cost of antidiabetic drugs in England 2015/16, by type
Net Ingredient Cost (NIC) of antidiabetic drugs (other than biguanides and sulfonylureas) in England in 2015/16 (in 1,000 GBP)
by Statista Research Department,
last edited
Aug 3, 2016
This statistic displays the Net Ingredient Cost (NIC) of antidiabetic drugs other than biguanides and sulfonylureas in England in 2015/16. In this year, the leading other antidiabetic drug in terms of net ingredient cost was Sitagliptin, costing approximately 93.7 million British pounds.
Net Ingredient Cost (NIC) of antidiabetic drugs (other than biguanides and sulfonylureas) in England in 2015/16 (in 1,000 GBP)
Loading statistic...
Expand statistic
| Net Ingredient Cost in thousand GBP | |
|---|---|
| Sitagliptin* | 93,690.6 |
| Pioglitazone Hydrochloride* | 17,320.7 |
| Linagliptin* | 31,389.9 |
| Liraglutide** | 47,577.3 |
| Saxagliptin* | 12,089.2 |
| Dapagliflozin* | 23,312.8 |
| Exenatide | 19,362.4 |
| Vildagliptin* | 5,219.1 |
| Repaglinide | 626.7 |
| Lixisenatide | 5,792.9 |
| Acarbose | 523.8 |
| Canagliflozin* | 7,944.6 |
| Alogliptin* | 4,772.7 |
| Nateglinide | 355.1 |
| Empagliflozin* | 1,900.9 |
| Dulaglutide | 693.5 |
| Rosiglitazone* | 0.2 |
| Net Ingredient Cost in thousand GBP | |
|---|---|
| Sitagliptin* | 93,690.6 |
| Pioglitazone Hydrochloride* | 17,320.7 |
| Linagliptin* | 31,389.9 |
| Liraglutide** | 47,577.3 |
| Saxagliptin* | 12,089.2 |
| Dapagliflozin* | 23,312.8 |
| Exenatide | 19,362.4 |
| Vildagliptin* | 5,219.1 |
| Repaglinide | 626.7 |
| Lixisenatide | 5,792.9 |
| Acarbose | 523.8 |
| Canagliflozin* | 7,944.6 |
| Alogliptin* | 4,772.7 |
| Nateglinide | 355.1 |
| Empagliflozin* | 1,900.9 |
| Dulaglutide | 693.5 |
| Rosiglitazone* | 0.2 |
© Statista 2019
About this statistic
Sources: Health and Social Care Information Centre; Public Health England
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
Aug 3, 2016
This statistic displays the Net Ingredient Cost (NIC) of antidiabetic drugs other than biguanides and sulfonylureas in England in 2015/16. In this year, the leading other antidiabetic drug in terms of net ingredient cost was Sitagliptin, costing approximately 93.7 million British pounds.
- Sources
- Health and Social Care Information Centre; Public Health England
- Show further sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- August 2016
- Region
- United Kingdom (England)
- Survey time period
- April 2005 to March 2016
- Supplementary notes
-
* includes combination with metformin.
** includes combination with insulin degludec.
The source also adds the following information: "Please note where drugs are shown to include combinations with metformin this is only where a combination product containing both drugs has been prescribed. There is no information on whether the combination of metformin and another Other antidiabetic drug is prescribed separately as patient information is not captured within the dataset."
Source
- Sources
- Health and Social Care Information Centre; Public Health England
- Show further sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- August 2016
More information
- Region
- United Kingdom (England)
- Survey time period
- April 2005 to March 2016
- Supplementary notes
-
* includes combination with metformin.
** includes combination with insulin degludec.
The source also adds the following information: "Please note where drugs are shown to include combinations with metformin this is only where a combination product containing both drugs has been prescribed. There is no information on whether the combination of metformin and another Other antidiabetic drug is prescribed separately as patient information is not captured within the dataset."
Other statistics on the topic
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Diabetes in Italy"
- Prevalence
The most important statistics
- Number of individuals suffering from diabetes in Italy from 2010 to 2017 (in 1,000 people)Italy: individuals with diabetes 2010-2017
- Share of individuals affected by Type II diabetes in Italy in 2006 and 2016Italy: share of individuals affected by Type II diabetes 2006-2016
- Share of individuals affected by diabetes in Italy in 2000 and 2016, by macro-regionItaly: prevalence of diabetes 2000-2016, by macro-region
- Number of individuals suffering from diabetes in Italy in 2017, by age group (in 1,000 people)Italy: individuals with diabetes 2017, by age group
- Share of individuals affected by diabetes in Italy in 2016, by age groupItaly: share of individuals affected by diabetes 2016, by age group
- Share of females affected by diabetes in Italy in 2000 and 2016, by age groupItaly: share of females affected by diabetes 2000-2016, by age group
- Share of males affected by diabetes in Italy in 2000 and 2016, by age groupItaly: share of males affected by diabetes 2000-2016, by age group
- Demographics and risk factors
The most important statistics
- Share of females aged 45 years and older suffering with diabetes in Italy in 2016, by age group and body mass indexItaly: women affected by diabetes 2016, by age and BMI
- Share of males aged 45 years and older suffering with diabetes in Italy in 2016, by age group and body mass indexItaly: men affected by diabetes 2016, by age and BMI
- Share of males affected by diabetes in Italy in 2017, by level of education and age groupItaly: males affected by diabetes 2017, by education level and age group
- Share of females affected by diabetes in Italy in 2017, by education level and age groupItaly: females affected by diabetes 2017, by education level and age
- Share of elderly population affected by diabetes in Italy in 2000 and 2016, by macro-regionItaly: prevalence of diabetes among elderly population 200-2016, by macro-region
- Share of cigarette smokers affected by a cardiovascular disorder in Italy between 2014 and 2017, by type Italy: cigarette smokers affected by cardiovascular disorder 2014-2017, by type
- Hospitalization and deaths
The most important statistics
- Rate of hospital discharges with diabetes as the main diagnosis in Italy as of 2015, by region (per 100,000 population)Italy: rate of hospital discharges for diabetes 2015, by region
- Total number of deaths from endocrine, nutritional and metabolic diseases in Italy in 2016, by genderItaly: number of deaths from endocrine, nutritional and metabolic diseases 2016
- Rate of deaths from diabetes among females in Italy from 2003 to 2014 (per 100,000 population)Italy: rate of deaths from diabetes among females 2003-2014
- Rate of deaths from diabetes among males in Italy from 2003 to 2014 (per 100,000 population)Italy: rate of deaths from diabetes among males 2003-2014
- Drugs and treatments
The most important statistics
- Number of patients treated for diabetes in Italy as of March 2017, by treatmentItaly: number of patients treated for diabetes 2017, by treatment
- Number of people* affected by diabetes receiving health care in Italy in 2016, by treatmentItaly: number of diabetics receiving health care 2016, by treatment
- Public expenditure per capita for antidiabetics in Italy in 2016, by type (in euros)Italy: public expenditure per capita for antidiabetics 2016, by type
- Sales value of drugs used to treat diabetes in Italy from 2011 to 2017 (in million euros)Italy: sales value of drugs used to treat diabetes 2011-2017
- Market share of treatments to cure diabetes in Italy as of 2016, by typeItaly: market share of antidiabetics 2016, by type
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Alpha-glucosidase inhibitors consumption per 1,000 inhabitants per day in Spain 2014
- Antidiabetic consumption per 1,000 inhabitants per day Spain 2014, by type
- Dipeptidyl peptidase-4 consumption per 1,000 inhabitants per day Spain 2014, by type
- Pioglitazone consumption per 1,000 inhabitants per day in Spain 2010-2014
- Sulfonylureas consumption per 1,000 inhabitants per day in Spain 2014, by type
- Antidiabetic combinations per 1,000 inhabitants per day in Spain 2014, by type
- Sales value of drugs used in diabetes in Spain 2004-2015
- Inpatients with diabetes in England and Wales 2013, by type
- Number of people treated for diabetes in France 2015, by region
- Share of adults with diabetes in England 2013, by gender and waist circumference
- Rate of people treated for diabetes in France 2015, by region
- Rate of people treated for diabetes in France 2014, by gender
- Users of eHealth solutions for Diabetes forecast by subsegment in Spain 2016-2022
- Anti-diabetics estimated market size in South Korea 2014-2020
- Measures by food manufacturers to encourage healthy eating United Kingdom (UK) 2016
- Italy: export value of the women's hosiery industry 2017, by country
- Government spending on environmental protection activities in the UK 2000-2016
Studies
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Prescribing for Diabetes, England 2007/08 to 2017/18
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Prescribed Drug Spending in Canada, 2018
- Prescription Cost Analysis, England 2018
- Drug Use Among Seniors in Canada, 2016
- Antibiotic use in the United Kingdom (UK)
- Prescribed Drug Spending in Canada, 2017
- Prescribing for Diabetes, England 2005/06 to 2015/16
- Prescription drug access and affordability an issue for nearly a quarter of all Canadian h...
- Prescription Cost Analysis, England 2014
- Prescribing by dentists, England 2013
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Prescribed Drug Spending in Canada, 2013
- Prescribed Drug Spending in Canada, 2016
Statistics on "Diabetes in Italy"
- Number of individuals suffering from diabetes in Italy from 2010 to 2017 (in 1,000 people)
- Share of individuals affected by Type II diabetes in Italy in 2006 and 2016
- Share of individuals affected by diabetes in Italy in 2000 and 2016, by macro-region
- Number of individuals suffering from diabetes in Italy in 2017, by age group (in 1,000 people)
- Share of individuals affected by diabetes in Italy in 2016, by age group
- Share of females affected by diabetes in Italy in 2000 and 2016, by age group
- Share of males affected by diabetes in Italy in 2000 and 2016, by age group
- Share of females aged 45 years and older suffering with diabetes in Italy in 2016, by age group and body mass index
- Share of males aged 45 years and older suffering with diabetes in Italy in 2016, by age group and body mass index
- Share of males affected by diabetes in Italy in 2017, by level of education and age group
- Share of females affected by diabetes in Italy in 2017, by education level and age group
- Share of elderly population affected by diabetes in Italy in 2000 and 2016, by macro-region
- Share of cigarette smokers affected by a cardiovascular disorder in Italy between 2014 and 2017, by type
- Rate of hospital discharges with diabetes as the main diagnosis in Italy as of 2015, by region (per 100,000 population)
- Total number of deaths from endocrine, nutritional and metabolic diseases in Italy in 2016, by gender
- Rate of deaths from diabetes among females in Italy from 2003 to 2014 (per 100,000 population)
- Rate of deaths from diabetes among males in Italy from 2003 to 2014 (per 100,000 population)
- Number of patients treated for diabetes in Italy as of March 2017, by treatment
- Number of people* affected by diabetes receiving health care in Italy in 2016, by treatment
- Public expenditure per capita for antidiabetics in Italy in 2016, by type (in euros)
- Sales value of drugs used to treat diabetes in Italy from 2011 to 2017 (in million euros)
- Market share of treatments to cure diabetes in Italy as of 2016, by type
- Defined daily dose of alpha-glucosidase inhibitors per 1,000 inhabitants per day in Spain in 2014, by type
- Defined daily dose of antidiabetics per 1,000 inhabitants per day in Spain in 2014, by type
- Defined daily dose of dipeptidyl peptidase-4 (DPP4) per 1,000 inhabitants per day in Spain in 2014, by type
- Defined daily dose of pioglitazone per 1,000 inhabitants per day in Spain from 2010 to 2014
- Defined daily dose of antidiabetic sulfonylurea drugs per 1,000 inhabitants per day in Spain in 2014, by type
- Defined daily dose of antidiabetic combinations per 1,000 inhabitants per day in Spain in 2014, by type
- Total sales value of drugs used in diabetes in Spain from 2004 to 2015 (in million euros)
- Share of inpatients with diabetes in England and Wales in 2013, by type
- Number of people treated for diabetes in France in 2015, by region
- Proportion of individuals who have diabetes in England in 2013, by gender and waist circumference
- Number of people treated for diabetes per 1,000 people in France in 2015, by region
- Number of people treated for diabetes per 1,000 people in France in 2014, by gender
- Users of eHealth solutions for Diabetes forecast by subsegment in Spain from 2016 to 2022 (in thousands)
- Estimated size of the anti-diabetic drugs market in South Korea from 2014 to 2020 (in trillion South Korean won)
- Which, if any, of the following measures do you think food manufacturers should take to help people eat more healthy?
- Export value of the Italian women's hosiery industry in 2017, by country (in 1,000 euros)
- Government spending on environmental protection activities in the United Kingdom (UK) from 2000 to 2016 (in million British pounds)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.